Walleye Capital
EW icon

Walleye Capital’s Edwards Lifesciences EW Stock Holding History

Walleye Capital’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.43M Buy
17,800
+14,500
+439% +$1.2M 0.01% 1755
2025
Q4 		$281K Buy
3,300
+2,500
+313% +$205K ﹤0.01% 3355
2025
Q3 		$62.2K Sell
800
-3,900
-83% -$305K ﹤0.01% 3915
2025
Q2 		$368K Sell
4,700
-18,100
-79% -$1.35M ﹤0.01% 2905
2025
Q1 		$1.65M Sell
22,800
-19,900
-47% -$1.42M 0.01% 1564
2024
Q4 		$3.16M Buy
42,700
+25,900
+154% +$1.81M 0.01% 1387
2024
Q3 		$1.11M Sell
16,800
-30,100
-64% -$2.19M ﹤0.01% 2556
2024
Q2 		$4.33M Sell
46,900
-22,400
-32% -$1.98M 0.01% 1395
2024
Q1 		$6.62M Sell
69,300
-19,500
-22% -$1.64M 0.01% 1099
2023
Q4 		$6.77M Buy
88,800
+50,300
+131% +$3.5M 0.01% 912
2023
Q3 		$2.67M Buy
38,500
+10,700
+38% +$860K 0.01% 1510
2023
Q2 		$2.62M Buy
27,800
+27,700
+27,700% +$2.41M 0.01% 1147
2023
Q1 		$8.27K Buy
+100
New +$7.86K ﹤0.01% 3572
2022
Q4 		– Sell
-11,500
Closed -$950K – 3312
2022
Q3 		$950K Buy
+11,500
New +$1.11M 0.02% 1021
2019
Q3 		– Sell
-300
Closed -$18K – 1988
2019
Q2 		$18K Sell
300
-300
-50% -$18.1K ﹤0.01% 1539
2019
Q1 		$38K Buy
+600
New +$34.2K 0.01% 1261

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Walleye Capital's EW Position: Q1 2026 in Review

Walleye Capital reduced its Edwards Lifesciences (EW) stake by 99% in Q1 2026, selling an estimated $22.3M and leaving 1,950 shares worth $156K. The position accounts for ﹤0.01% of the portfolio, ranked #3471.

Walleye Capital first reported a position in EW in Q1 2019 and has held it in 13 quarters since. The position peaked at $23.3M in Q4 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Walleye Capital held 1,950 shares of Edwards Lifesciences worth $156K as of Q1 2026.
  • Walleye Capital sold 270,921 Edwards Lifesciences shares in Q1 2026, an estimated $22.3M.
  • Edwards Lifesciences made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #3471 holding.
  • Walleye Capital first reported a position in Edwards Lifesciences in Q1 2019 and has held it in 13 quarters since.
  • Walleye Capital's Edwards Lifesciences position peaked at $23.3M in Q4 2025.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.